AcrobiosystemsLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Yiding Chen
Chief executive officer
CN¥2.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 23.6% |
| Management average tenure | no data |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Acrobiosystems Co.,Ltd. (SZSE:301080) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Feb 12
AcrobiosystemsLtd's (SZSE:301080) Anemic Earnings Might Be Worse Than You Think
Nov 06Investors Appear Satisfied With Acrobiosystems Co.,Ltd.'s (SZSE:301080) Prospects As Shares Rocket 27%
Oct 01Why We're Not Concerned About Acrobiosystems Co.,Ltd.'s (SZSE:301080) Share Price
Jul 15AcrobiosystemsLtd's (SZSE:301080) Weak Earnings Might Be Worse Than They Appear
May 02CEO
Yiding Chen (48 yo)
Mr. Yiding Chen is General Manager & Chairman of the Board of Acrobiosystems Co.,Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | no data | CN¥2.06m | 23.62% CN¥ 2.3b | |
| Deputy GM & Director | no data | CN¥1.27m | 8.81% CN¥ 863.3m | |
| Deputy GM & Director | 2.3yrs | CN¥1.01m | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Non-Independent Director | 2.3yrs | no data | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Independent Director | 5.4yrs | no data | no data | |
| Employee Supervisor | no data | no data | no data | |
| Independent Director | 2.3yrs | no data | no data | |
| Non-Employee Supervisor | 3.5yrs | no data | no data | |
| Employee Supervisor | 2.3yrs | no data | no data |
Experienced Board: 301080's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/30 07:53 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Acrobiosystems Co.,Ltd. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yuan Gao | China International Capital Corporation Limited |
| Shiyu Chen | China International Capital Corporation Limited |